JP2016500660A5 - - Google Patents

Download PDF

Info

Publication number
JP2016500660A5
JP2016500660A5 JP2015534747A JP2015534747A JP2016500660A5 JP 2016500660 A5 JP2016500660 A5 JP 2016500660A5 JP 2015534747 A JP2015534747 A JP 2015534747A JP 2015534747 A JP2015534747 A JP 2015534747A JP 2016500660 A5 JP2016500660 A5 JP 2016500660A5
Authority
JP
Japan
Prior art keywords
capromorelin
composition
companion animal
oral
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015534747A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016500660A (ja
JP6779618B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/062227 external-priority patent/WO2014052780A2/en
Publication of JP2016500660A publication Critical patent/JP2016500660A/ja
Publication of JP2016500660A5 publication Critical patent/JP2016500660A5/ja
Application granted granted Critical
Publication of JP6779618B2 publication Critical patent/JP6779618B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015534747A 2012-09-27 2013-09-27 食欲不振制御化合物の組成物および使用方法 Active JP6779618B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261706164P 2012-09-27 2012-09-27
US61/706,164 2012-09-27
PCT/US2013/062227 WO2014052780A2 (en) 2012-09-27 2013-09-27 Compositions and methods of use of an inappetance-controlling compound

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018041063A Division JP6796097B2 (ja) 2012-09-27 2018-03-07 食欲不振制御化合物の組成物および使用方法

Publications (3)

Publication Number Publication Date
JP2016500660A JP2016500660A (ja) 2016-01-14
JP2016500660A5 true JP2016500660A5 (enExample) 2016-11-10
JP6779618B2 JP6779618B2 (ja) 2020-11-04

Family

ID=50339468

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015534747A Active JP6779618B2 (ja) 2012-09-27 2013-09-27 食欲不振制御化合物の組成物および使用方法
JP2018041063A Active JP6796097B2 (ja) 2012-09-27 2018-03-07 食欲不振制御化合物の組成物および使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018041063A Active JP6796097B2 (ja) 2012-09-27 2018-03-07 食欲不振制御化合物の組成物および使用方法

Country Status (18)

Country Link
US (1) US11090292B2 (enExample)
EP (3) EP2906041A4 (enExample)
JP (2) JP6779618B2 (enExample)
KR (6) KR20230097201A (enExample)
CN (2) CN111419845A (enExample)
AR (2) AR092713A1 (enExample)
AU (2) AU2013323349B2 (enExample)
BR (1) BR112015006282B1 (enExample)
CA (1) CA2886091C (enExample)
DK (1) DK3524260T3 (enExample)
ES (1) ES2959427T3 (enExample)
MX (2) MX2015003564A (enExample)
NZ (2) NZ707174A (enExample)
PL (1) PL3524260T3 (enExample)
PT (1) PT3524260T (enExample)
RU (1) RU2648958C2 (enExample)
TW (3) TW202106298A (enExample)
WO (1) WO2014052780A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120131183A (ko) 2010-02-26 2012-12-04 라퀄리아 파마 인코포레이티드 악액질 치료용 그렐린 수용체 작용제
WO2013119800A1 (en) 2012-02-07 2013-08-15 Massachusetts Institute Of Technology Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
RU2648958C2 (ru) 2012-09-27 2018-03-28 Аратана Терапьютикс, Инк. Композиции и способы применения соединения для борьбы с отсутствием аппетита
WO2014144231A1 (en) 2013-03-15 2014-09-18 Massachusetts Institute Of Technology Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
KR20180108916A (ko) * 2015-01-28 2018-10-04 아라타나 세라퓨틱스, 인크. 체중-증량 화합물의 장기 사용을 위한 조성물 및 방법
WO2016138099A1 (en) 2015-02-24 2016-09-01 Massachusetts Institute Of Technology Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
AU2017358013B2 (en) * 2016-11-11 2020-08-06 Dsm Ip Assets B.V. Compositions and methods of pet food

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US193273A (en) * 1877-07-17 Improvement in material for pulley-covers
JP2893901B2 (ja) * 1990-09-07 1999-05-24 株式会社岐阜免疫研究所 動物用抗体含有油性ペースト製剤
CA2095786A1 (en) * 1992-05-08 1993-11-09 Franco J. Vaccarino Method of stimulating appetite
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
ATE446758T1 (de) 2000-05-31 2009-11-15 Pfizer Prod Inc Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts
EP1181933A3 (en) * 2000-06-29 2002-04-10 Pfizer Products Inc. Use of growth hormone secretagogues for stimulating or increasing appetite
US8309603B2 (en) * 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
US7476653B2 (en) * 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
US7491695B2 (en) * 2003-06-18 2009-02-17 Tranzyme Pharma Inc. Methods of using macrocyclic modulators of the ghrelin receptor
US20080171700A1 (en) * 2004-04-07 2008-07-17 Gastrotech Pharma A/S Use Of Secretagogue For The Teatment Of Ghrelin Deficiency
EP1812045A2 (en) * 2004-10-27 2007-08-01 Gastrotech Pharma A/S Uses of secretagogues for treatment of organ transplant patients
EP1956923A1 (en) * 2005-11-02 2008-08-20 Nestec S.A. Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
CN101443358B (zh) * 2006-03-13 2016-05-11 利亚特·明茨 生长素释放肽剪接变体在治疗恶病质和/或压食和/或厌食-恶病质和/或营养不良和/或脂肪营养障碍和/或肌肉消耗和/或刺激食欲中的用途
ES2436419T3 (es) * 2006-09-27 2014-01-02 Ipsen Pharma S.A.S. Análogos de ghrelina sustituidos en el N terminal
JP2008127377A (ja) * 2006-11-24 2008-06-05 Jichi Medical Univ Ghs−r作動薬を含有してなるメタボリックシンドローム又は高血圧症の予防・治療剤。
US20080226802A1 (en) * 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Beverage having natural sweeteners with one or more stevia components and source of berry
TWI429436B (zh) * 2007-04-10 2014-03-11 Helsinn Therapeutics Us Inc 使用生長激素促泌素治療或預防嘔吐之方法
RU2007129408A (ru) * 2007-07-31 2009-02-10 Игорь Николаевич Жирков (RU) Способ выращивания поросят в период откорма
FR2920295B1 (fr) * 2007-09-05 2009-12-11 Desvac Dispositif d'injection de produits veterinaires a des volailles, comprenant un element de contention presentant une forme anatomique incluant des moyens de calage d'un os reperable
EP2215914B1 (en) * 2007-11-12 2013-04-24 San-Ei Gen F.F.I., INC. Method of improving sweetness qualities of stevia extract
JP5552481B2 (ja) * 2009-03-26 2014-07-16 武田薬品工業株式会社 ピラゾール化合物
KR20120131183A (ko) * 2010-02-26 2012-12-04 라퀄리아 파마 인코포레이티드 악액질 치료용 그렐린 수용체 작용제
RU2648958C2 (ru) 2012-09-27 2018-03-28 Аратана Терапьютикс, Инк. Композиции и способы применения соединения для борьбы с отсутствием аппетита

Similar Documents

Publication Publication Date Title
JP2016500660A5 (enExample)
Krautwald-Junghanns et al. Aspergillosis in birds: an overview of treatment options and regimens
JP2010504337A (ja) イヌの認知機能障害症候群の治療のためのディメボン(dimebon)などの水素化ピリド[4,3−b]インドール
RU2015114996A (ru) Композиции и способы применения соединения для борьбы с отсутствием аппетита
HRP20180774T1 (hr) Orodisperzibilni dezmopresin za povećanje početnog razdoblja sna neometanog s nokturijom
JP2017534613A (ja) デクスメデトミジン製剤を使用する睡眠障害の予防または治療
US10117890B2 (en) Methods and compositions for treating pain
JP2016525548A5 (enExample)
US20240285576A1 (en) R-mdma for treatment of pain
US20140079827A1 (en) Methods for improving health in animals
Govic et al. In vivo electrophysiological recordings in amygdala subnuclei reveal selective and distinct responses to a behaviorally identified predator odor
KR20090014183A (ko) 액상 약제학적 제제
CN103751201A (zh) 一种犬、猫用抗寄生虫口服崩解片及其制备方法
RU2016137926A (ru) Композиции грапипранта и способы их применения
NZ731518A (en) Formulations of a pi3k/mtor-inhibitor for intravenous administration
JP2013542737A (ja) 昆虫侵入を阻害するための方法
US20230255885A1 (en) Chemotherapeutic pharmaceutical suspension for oral dosage
EP3366288B1 (en) Lithium ascorbate exhibiting anti-stress, anxiolytic and anti-depression activity
CN101129188A (zh) 一种水飞蓟素咀嚼片及其制备方法
US20150320783A1 (en) N-methylserotonin and related substances for use in treating / lessening the occurrence of hot flashes related to menopause
KR101783306B1 (ko) PDKs 억제제를 유효성분으로 함유하는 알러지성 질환의 예방 또는 치료용 약학적 조성물
JP2017513866A5 (enExample)
JP2013518045A (ja) ウマ科のウマバエの幼虫を内部抑制または処置する方法
WO2017084631A1 (zh) 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法
US20100227891A1 (en) Threshold blood omeprazole concentration is 50 ng/ml for the maintenance of intragastric ph of at least 4.0 after oral dosing with cma-omeprazole, agn 201904-z